Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 27 June 1969:
Vol. 164. no. 3887, pp. 1522 - 1523
DOI: 10.1126/science.164.3887.1522

Articles

Glycolipid and Mucopolysaccharide Abnormality in Fibroblasts of Fabry's Disease

Reuben Matalon 1, Albert Dorfman 1, Glyn Dawson 2, and Charles C. Sweeley 2

1 Departments of Pediatrics and Biochemistry, Joseph P. Kennedy, Jr., Mental Retardation Center, LaRabida-University of Chicago Institute, University of Chicago, Chicago, Illinois
2 Department of Biochemistry, Michigan State University, East Lansing

Cultures of skin fiibroblasts from a patient with Fabry's disease showed an accumulation of the glycolipid, galactosyl-galactosyl-glucosyl ceramide. Such cells also showed metachromasia on staining with toluidine blue and a markedly elevated acid mucopolysaccharide content.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Lactosyl Ceramidosis: Catabolic Enzyme Defect of Glycosphingolipid Metabolism.
G. Dawson and A. O. Stein (1970)
Science 170, 556-558
   Abstract »    PDF »
Genetic Inactivation of the agr-Galactosidase Locus in Carriers of Fabry's Disease.
G. Romeo and B. R. Migeon (1970)
Science 170, 180-181
   Abstract »    PDF »
Enzyme Replacement in Fabry's Disease, an Inborn Error of Metabolism.
C. A. Mapes, R. L. Anderson, C. C. Sweeley, R. J. Desnick, and W. Krivit (1970)
Science 169, 987-989
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)